Ovarian cancer multi-drug resistant cell line induced by triptolide and its application
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- HARBIN MEDICAL UNIVERSITY
- Publication Date
- 2018-03-09
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to a drug-resistant human ovarian cancer cell line and use thereof, in particular to the establishment of multi-drug resistance of ovarian cancer by gradually increasing the action concentration of a chemotherapeutic drug triptolide (TPL) by using human ovarian cancer SKOV3 as a parental cell. The cell line SKOV3 / TPL belongs to the field of tumor biology. Background technique
[0002] In the latest worldwide statistics on the incidence of tumors, the incidence of ovarian cancer ranks third among the malignant tumors of female reproductive organs, and the mortality rate ranks first, which seriously endangers women's health and life. Chemotherapy is one of the important means of ovarian cancer treatment and plays an important role in the comprehensive treatment of ovarian cancer, but clinical chemotherapy resistance is the main reason for the failure of ovarian cancer chemotherapy. The development of drug resistance is multifactori...